KFSH Advances Gene Therapy for Sickle Cell Disease Using Patients’ Own Modified Stem Cells
Financial Post · · g108410
RIYADH, Saudi Arabia, Oct. 23, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is advancing gene therapy for sickle cell disease through a 2026 clinical trial that uses the patient’s own hematopoietic stem cells, genetically modified to address the underlying defect and offer a potential path beyond repeated supportive treatment. Read More